A U.S. Centers for Disease Control and Prevention (CDC) official has confirmed that a Missouri patient with bird flu (H5N1) was not severely ill and received antiviral medications. The patient was hospitalized due to an underlying medical condition, and the CDC is investigating how, when, and where the individual was exposed to the virus.
While the CDC’s epidemiologists are still working to identify the exact source of exposure, no clear link has been found. The CDC has also not determined whether the virus is related to a cattle outbreak. Current evidence suggests this is an isolated case, as no additional infections have been identified.
To protect agricultural workers, the CDC will launch a seasonal flu vaccination campaign starting in October. They will partner with five commercial lab companies—Aegis, ARUP, Ginkgo Bioworks, LabCorp, and Quest Diagnostics—for testing. The CDC plans to invest $5 million into this initiative by the end of September, with potential funding scaling up to $118 million over the next five years if necessary.
In related news, the U.S. Department of Agriculture (USDA) reported that eight dairy herds in California tested positive for bird flu. All infected herds are quarantined, and California state officials are expected to conduct bulk milk testing around the affected areas. The USDA also plans to begin field safety studies on bird flu vaccines in cattle to prevent further spread of the disease.
Despite these findings, there is no evidence of person-to-person transmission of the virus, and the Missouri patient has not reported consuming any raw dairy products. Additionally, the USDA has noted that the rate of bird flu transmission among dairy cows has slowed.
The CDC continues to communicate closely with Missouri state officials, though they have not been invited to conduct an on-site investigation. For now, the situation remains under control, and health authorities will keep monitoring any developments.
